Unique ID issued by UMIN | UMIN000019228 |
---|---|
Receipt number | R000022220 |
Scientific Title | A Randomised Controlled Trial Investigating the Effectiveness of AI (Artificial Intelligence)-enhanced Internet Cognitive Behavioral Therapy (AI-ICBT) for Adult Depression |
Date of disclosure of the study information | 2015/10/04 |
Last modified on | 2023/12/30 08:58:30 |
A Randomised Controlled Trial Investigating the Effectiveness of AI (Artificial Intelligence)-enhanced Internet Cognitive Behavioral Therapy (AI-ICBT) for Adult Depression
A trial for the assessment of the effectiveness of AI-ICBT on Japanese adults with depression as compared to standalone ICBT (AI-ICBT study)
A Randomised Controlled Trial Investigating the Effectiveness of AI (Artificial Intelligence)-enhanced Internet Cognitive Behavioral Therapy (AI-ICBT) for Adult Depression
A trial for the assessment of the effectiveness of AI-ICBT on Japanese adults with depression as compared to standalone ICBT (AI-ICBT study)
Japan |
Depression
Psychiatry | Adult |
Others
NO
To assess the clinical- and cost- effectiveness of AI-ICBT on Japanese adults with depression as compared to standard ICBT without AI function or waiting list
Efficacy
Exploratory
PHQ-9 (Patient Health Questionnaire) at baseline and follow-up (7 weeks and 3 months after intervention)
QIDS (Quick Inventory of Depressive Symptomatology), GAD-7 (Generalized Anxiety Disorder 7-item (GAD-7) scale), ODSIS (Overall Depression Severity and Impairment Scale),OASIS (Overall Anxiety Severity And Impairment Scale), SDISS (Sheehan Disability Scale) & Medical costs
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Active
YES
NO
Institution is not considered as adjustment factor.
YES
Central registration
3
Treatment
Device,equipment | Behavior,custom |
Weekly self-help intervention by AI-enhanced ICBT over seven weeks
Weekly self-help intervention by standard ICBT without AI function over seven weeks
Wait-list
20 | years-old | <= |
60 | years-old | >= |
Male and Female
-Regular access to the Internet
-A score of 5 or more on the PHQ-9
-Ability to both understand and agree
with informed consent in Japanese
-Receiving any other CBT
-Strong suicidal ideation
-Schizophrenia
-Dementia
-Any substance addiction (except nicotine
addiction) during the 12 months prior to
the trial
-(For patients receiving treatment by a
mental health specialist/therapist)
Unavailability of therapist's permission for the patient to participate in the trial
900
1st name | Mirai |
Middle name | |
Last name | So |
Keio University School of Medicine
Department of Neuropsychiatry
160-8582
35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan
+81-(0)3-3353-1211
mirai.so@keio.jp
1st name | Mirai |
Middle name | |
Last name | So |
Keio University School of Medicine
Department of Neuropsychiatry
160-8582
Department of Neuropsychiatry
+81-(0)3-3353-1211
ghh13250@gmail.com
The Research Institute of Economy, Trade and Industry
The Research Institute of Economy, Trade and Industry
Other
NIKKEI RESEARCH INC.
NEC Solution Innovators, Ltd
Hiramatsu Memorial Hospital
1-20 Minami 22 Nishi 14, Sapporo, Hokkaido, Japan
011-561-0708
webmaster@hiramatu-mhp.or.jp
NO
株式会社 日経リサーチ社
NIKKEI RESEARCH INC.
2015 | Year | 10 | Month | 04 | Day |
Published
https://www.rieti.go.jp/jp/publications/summary/16110002.html
1187
Completed
2015 | Year | 08 | Month | 01 | Day |
2015 | Year | 09 | Month | 28 | Day |
2015 | Year | 10 | Month | 05 | Day |
2016 | Year | 06 | Month | 30 | Day |
2016 | Year | 05 | Month | 15 | Day |
2016 | Year | 06 | Month | 20 | Day |
2015 | Year | 10 | Month | 04 | Day |
2023 | Year | 12 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022220